Walcheren Hospital - Oosterschelde Hospitals

The NMa Board concludes that, if no conditions were attached to the licence, the proposed concentration would significantly restrict effective competition on the markets for clinical general hospital care and non-clinical general hospital care in Central Zeeland, in particular by creating or strengthening a dominant position.

In view of the parties' commitments, as described in points 151 to 166 and contained in the appendix that forms an integral part of this decision, the NMa Board concludes that, provided the commitments are properly fulfilled, the proposed concentration will not significantly restrict effective competition on the Dutch market or any part of it, in particular by creating or strengthening a dominant position.

In view of the foregoing, the NMa Board announces that a licence is granted for the concentration to which the licence application relates.

The licence is granted subject to the following conditions:

a. The parties shall, following the concentration, submit to a price ceiling for B-sector DTCs.
b. The parties shall, following the concentration, realise certain quality improvements, within the periods specified in the appendix to this decision.
c. The parties shall facilitate entry to the market for existing and future providers of specialist medical care.
d. The conditions specified in clauses a, b and c shall be fulfilled as provided for in the appendix to this decision, which appendix forms an integral part of this decision.